Vancomycin (Mylan, Hoeilaart, Belgium) |
Ceftazidim (Kefadim®, Eurocept Pharmaceuticals, Ankeeven, The Netherlands) |
Piperacillin-tazobactam (Mylan, Hoeilaart, Belgium) |
Amoxicillin (Clamoxyl®, Sandoz, Vilvoorde, Belgium) |
Metronidazole (B Braun Medical, Diegem, Belgium) |
Cefuroxime (Zinacef®, GlaxoSmithKline Pharmaceuticals, Wavre, Belgium) |
Temocillin (Negaban®, Eumedica SA, Manage, Belgium) |
Insulin (Actrapid®, Novo Nordisk, Brussels, Belgium) |
Norepinephrine (Aguetant SA/NV, Brussels, Belgium) |
Nadroparine (Fraxiparine®, Movianto, Aspen, USA) |
Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | Day | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
GGT (NV=<40 IU/L) | 65 | 126 | 305 | 700 | 1172 | 1640 | 1874 | 1507 | 1520 | 1160 | 1267 | 990 |
Alkaline phosphatase (NV=35-105 IU/L) | 125 | 250 | 369 | 540 | 659 | 734 | 736 | 636 | 626 | 560 | 673 | 549 |
AST (NV=13-35 IU/L) | 29 | 114 | 80 | 35 | 28 | 23 | 24 | 20 | 22 | 22 | 21 | 17 |
ALT (NV=7-35 IU/L) | 15 | 19 | 41 | 56 | 57 | 50 | 41 | 40 | 37 | 35 | 37 | 37 |
Total bilirubin (NV=<1.2 mg/dL) | 0.9 | 1.1 | 1.1 | 1.3 | 1.4 | 1.3 | 1.2 | 1.2 | 1.1 | 0.9 | 0.9 | 0.9 |
INR (NV=0.80-1.20) | 2.09 | 2.11 | 1.57 | 1.59 | 1.47 | 1.4 | 1.36 | 1.35 | 1.32 | 1.26 | 1.26 | 1.27 |
Ammonaemia (NV=<90 μg/dL) | - | 179 | 167 | 155 | 139 | 153 | 99 | 79 | 97 | 88 | 111 | 63 |
Triglycerides (NV=< 150 mg/dL) | - | - | 454 | 438 | 498 | 608 | 604 | - | 444 | 338 | 303 | 223 |
Arterial lactate (NV=<2.2 mmol/L) | - | 10.4 | 2.9 | 2.0 | 1.3 | 1.4 | 1.9 | 2.0 | 1.5 | 1.4 | 1.9 | 1.9 |
Urine creatinine) lactate (NV=<50 mmol/mmol | - | 1190 | - | - | - | - | - | - | - | - | - | - |
Parenteral nutrition | Stop | - | - | - | - | - | - | - | - | - | - | - |
Enteral nutrition | No | No | 500 ml | No | 500 ml | 500 ml | 500 ml | 500 ml | 500 ml | 500 ml | 500 ml | 500 ml |
Glucose supplementation | - | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |